Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,599.00
Bid: 1,594.50
Ask: 1,595.50
Change: -19.00 (-1.17%)
Spread: 1.00 (0.063%)
Open: 1,608.00
High: 1,615.00
Low: 1,575.00
Prev. Close: 1,618.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MARKET PULSE-Apple, Sony, Oncolytics, Biodel, BlackBerry

Mon, 09th Sep 2013 12:15

(For more market insights, including options activity, click on ; for the Day Ahead newsletter http://link.reuters.com/mex49s; for the Morning News Call newsletter, http://link.reuters.com/nex49s)

Sept. 9 (Reuters) - Some U.S. stocks to watch on Monday:

FUTURES RISE AFTER CHINA DATA; SYRIA CONCERNS REMAIN

U.S. stock index futures advanced in the wake of upbeateconomic data from China, though concerns remained about apotential strike against Syria. S&P 500 futures rose 3.3points and were above fair value, a formula that evaluatespricing by taking into account interest rates, dividends andtime to expiration on the contract. Dow Jones industrial averagefutures gained 25 points, and Nasdaq 100 futures added 11.75 points.

** APPLE INC, Friday close $498.22, up 1.2 pctpremarket

Brokerage FBN Securities raised its price target on thecompany's stock to $600 from $575 in anticipation of Applemaking an announcement of its iPhone 5S and iPhone 5C onTuesday. The brokerage said it expected the phones to startshipping on Sept. 20. FBN sees the iPhone 5C as an opportunityfor Apple to be successful in China.

** ONCOLYTICS BIOTECH INC, Friday close $2.65, up17 pct premarket

The company said its cancer drug, Reolysin, reduced the sizeof tumors in 92 percent of lung cancer patients in a mid-stagetrial.

** BIODEL INC, Friday close $5.03, up 12 pctpremarket

The pharmaceutical company said on Sunday that preliminarydata showed its fast-acting regular human insulin BIOD-123 metits goal in a mid-stage trial.

** ISIS PHARMACEUTICALS INC, Friday close $27.92,up 7 pct premarket

Biogen Idec Inc has agreed to pay another $100million upfront to the drugmaker as a part of a broadcollaboration to develop new medicines for neurologicaldisorders, the companies said.

** BLACKBERRY LTD, Friday close $10.84, up 4.3 pctpremarket

The company's largest shareholder, Prem Watsa, has assembledbillions in backing from Canada's biggest pension funds for abid, The Sunday Times reported on Sunday. (http://link.reuters.com/caz82v)

Watsa is the founder and chairman of Fairfax FinancialHoldings Ltd that holds about 10 percent stake in the company.

** SMITHFIELD FOODS INC, Friday close $33.92, up 2pct after market

The U.S. Committee on Foreign Investment has cleared the wayfor Shuanghui International Holdings Ltd's proposed $4.7 billionacquisition of Smithfield Foods, the companiessaid.

** JOHNSON & JOHNSON, Friday close $87.16, up 1 pctpremarket

The company has launched a sale process for its OrthoClinical Diagnostics unit, which makes blood screening equipmentand laboratory blood tests and could fetch around $5 billion.J&J has asked JPMorgan Chase & Co to run the sale and ispreparing to send detailed financial information in coming weeksto potential buyers.

** VODAFONE PLC, Friday close $32.89

The company may fail to reach the 75 percent threshold ofacceptances from shareholders needed to clinch Germany's largestcable operator Kabel Deutschland, the Financial Timessaid. Vodafone agreed a 7.7 billion euro ($10.13 billion) offerfor Kabel Deutschland in June, a near 40 percent premium toKabel's share price before its interest first emerged.

** SONY CORP, Friday close $21.02, down 2 pct aftermarket

The electronics maker announced the Japanese release of itsPlayStation 4 on Monday as the company braces for a gamingconsole war with Microsoft Corp that could make orbreak the Japanese firm's struggle to return to profit.

** GLAXOSMITHKLINE PLC, Friday close $51.67

Japan's Suntory Beverage & Food Ltd is to buyGlaxoSmithKline's Lucozade and Ribena brands for 1.35 billionpounds ($2.11 billion) to expand into new markets.

** GOOGLE INC, Friday close $879.58

The U.S. government tapped into computer networks ofcompanies including Google and Brazilian state-run oil firmPetroleo Brasileiro SA, according to leaked U.S.documents aired by Globo, Brazil's biggest television network.

** TIME WARNER INC, Friday close $61.45

The entertainment company is planning to transfer its U.S.retirees from company-sponsored health plans and move them toprivate insurance exchanges. According to an August memoobtained by Reuters, the media company will make allocations toa Health Reimbursement Arrangement account for retirees to usetowards the purchase of coverage on an exchange. Previously,Time Warner provided an indirect subsidy through a supplementaryMedicare program. (Compiled by Varun Aggarwal; Editing by Kirti Pandey)

More News
20 Jun 2024 16:01

Industry groups back drugmakers' appeal in Zantac cancer lawsuits

June 20 (Reuters) - A bid by GSK and other drugmakers to stop more than 70,000 lawsuits in Delaware over discontinued heartburn drug Zantac has received the backing of leading U.S. industry groups, including the United States Chamber of Commerce and Pharmaceutical Research and Manufacturers of America.

Read more
11 Jun 2024 14:31

Zantac litigation fears overdone at GSK, says Shore Capital

(Sharecast News) - Volatile moves in GSK's share price are likely to persist in the near term as a result of ongoing Zantac-related litigation, but the long-term investment case is "still appealing", according to Shore Capital, which kept a 'buy' rating on the stock.

Read more
11 Jun 2024 09:32

TOP NEWS: GSK takes first steps to appeal Zantac ruling in Delaware

(Alliance News) - GSK PLC on Tuesday said it has taken the first steps to seek appeal of a ruling by the Delaware Superior Court in regard to its discontinued heartburn drug Zantac.

Read more
11 Jun 2024 09:12

LONDON MARKET OPEN: FTSE 100 up; UK unemployment rises to 4.4%

(Alliance News) - Stock prices in London opened higher on Tuesday, after a difficult day for markets on Monday amid the EU election fallout.

Read more
11 Jun 2024 07:52

LONDON BRIEFING: FTSE 100 called up despite unemployment rise

(Alliance News) - The FTSE 100 in London was called to open higher on Tuesday, after data showed that unemployment in the UK unexpectedly rose.

Read more
11 Jun 2024 07:22

GSK launches appeal to recent Zantac ruling

(Sharecast News) - GSK has started the process of appealing a recent decision by the Delaware Superior Court regarding the ongoing Zantac, or ranitidine, litigation, it announced on Tuesday.

Read more
11 Jun 2024 00:32

GSK asks to appeal Delaware ruling allowing Zantac cases to go forward

June 10 (Reuters) -

Read more
10 Jun 2024 22:49

Latest trial over Zantac cancer claims called off as plaintiff drops case

June 10 (Reuters) - A woman who claimed in a lawsuit that GSK's discontinued heartburn drug Zantac caused her breast cancer dropped her case shortly before it was set to go to trial in Illinois state court on Monday, the company announced.

Read more
10 Jun 2024 19:00

TOP NEWS: GSK welcomes dismissal of Zantac case in Illinois

(Alliance News) - GSK PLC on Monday welcomed the dismissal of a case in the US concerning the heartburn drug, Zantac, which was due to start on Monday.

Read more
10 Jun 2024 12:42

EU to secure 40 million avian flu vaccines for 15 countries - officials

BRUSSELS, June 10 (Reuters) - The EU will sign a contract on Tuesday to secure over 40 million doses of a preventative avian flu vaccine for 15 countries with the first shipments heading to Finland, EU officials said on Monday.

Read more
10 Jun 2024 08:39

GSK gets FDA approval for Arexvy vax in 50-59 year olds at risk of RSV

(Alliance News) - GSK PLC on Monday announced that the US Food & Drug Administration has approved an expanded age indication for its respiratory syncytial virus vaccine.

Read more
10 Jun 2024 07:37

LONDON BRIEFING: FTSE called down amid political uncertainty in EU

(Alliance News) - Stocks in London are called to open lower on Monday, setting off the week on the backfoot, with eyes on the US Federal Reserve's latest interest rate decision.

Read more
10 Jun 2024 07:17

GSK's Arexvy vaccine approved for wider age range

(Sharecast News) - US regulators have approved the use of GSK's Arexvy vaccine for a younger age group, the biopharma group announced on Monday.

Read more
7 Jun 2024 19:34

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, June 7 (Reuters) - The outbreak of bird flu in U.S. dairy cows has now been confirmed in Minnesota and Iowa, bringing to 11 the total number of affected states, which have been encouraged to ramp up testing efforts at the request of government officials.

Read more
5 Jun 2024 09:52

LONDON BROKER RATINGS: Berenberg raises Taylor Wimpey to 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.